Tirzepatide 40mg (R&D Only)

Tirzepatide 40mg UK availability is one of the most common research queries we receive — this page covers everything you need before ordering, including mechanism, purity testing, and storage guidance.

What Is Tirzepatide?

Tirzepatide is a synthetic dual agonist targeting both GIP and GLP-1 receptors simultaneously. This 40mg vial is a higher-concentration format of the same research compound available in our 10mg listing, intended for R&D protocols requiring a larger total quantity per vial — reducing the number of reconstitution cycles needed across an extended study.

ApexPure supplies Tirzepatide 40mg strictly for R&D and laboratory research purposes, manufactured as a lyophilised, research-grade compound. Its dual-receptor design is the central research variable of interest, allowing scientists to study combined metabolic-pathway activation not possible with single-agonist compounds.

Research Applications

Research literature has explored the combined GIP/GLP-1 agonism mechanism in relation to glucose-homeostasis and energy-metabolism research models in preclinical settings. Comparative studies have examined whether dual-receptor activation produces different or additive effects compared with GLP-1-only agonism. The higher-concentration 40mg format is often selected for longer-running R&D protocols or comparative studies requiring consistent material across multiple research sessions without reconstituting a new vial each time.

Background & Research History

Tirzepatide was developed as researchers sought to combine the research-established GLP-1 agonist mechanism with GIP receptor activity, based on evidence that GIP receptor engagement might produce complementary metabolic research effects. It represents a deliberate evolution beyond single-target incretin compounds. See our GLP-1 Research Peptides Explained guide for a full comparison against Semaglutide and Retatrutide.

Purity & Third-Party Testing

Each batch of this 40mg vial is independently HPLC-verified to a minimum of 99% purity, with a downloadable Certificate of Analysis matched to the specific batch, available on this product listing. Higher-concentration formats are held to exactly the same testing threshold as our standard vials — concentration does not change our purity standard.

Reconstitution & Storage Guidelines

Keep the lyophilised vial frozen at -18°C or below, shielded from light. Once reconstituted, refrigerate at 2-8°C and avoid repeated freeze-thaw cycles to preserve compound integrity. Given the higher total quantity in this format, R&D teams running extended protocols should pay particular attention to consistent reconstitution volume across sessions to maintain accurate concentration calculations.

Handling Notes for Researchers

Tirzepatide 40mg should be handled only by qualified laboratory personnel using appropriate PPE, following institutional protocols for reconstitution, storage, and disposal. This product is not supplied for human use of any kind and is intended strictly for R&D applications.

Why Buy Tirzepatide 40mg UK From ApexPure

ApexPure was built around one standard: every batch we sell is independently tested before it reaches your laboratory, and every Certificate of Analysis is published, not hidden behind a support request. This 40mg format is popular with laboratories running longer or higher-volume Tirzepatide research protocols, and we test it to exactly the same independent HPLC standard as every other compound in our Weight Management range. Orders are dispatched from the UK, so researchers avoid the customs delays and cold-chain uncertainty that come with importing from overseas suppliers. If a batch does not meet our purity threshold, it does not go on sale — that is the certification promise behind the ApexPure name. Read more about our testing process, or check our FAQ for common questions about ordering and dispatch.

Frequently Asked Questions

How does the 40mg vial differ from the 10mg version?
Both are the same research compound at the same purity standard — the 40mg format simply provides a larger total quantity per vial, suited to extended or higher-volume R&D protocols.

Is Tirzepatide 40mg tested to the same standard as the 10mg vial?
Yes. Every batch, regardless of concentration, is independently HPLC-verified to a minimum of 99% purity with a matched Certificate of Analysis.

Is this compound licensed for clinical use in the UK?
No — Tirzepatide is supplied by ApexPure exclusively as an unlicensed research chemical for R&D and laboratory investigation, with no therapeutic claims made.

This product is sold strictly for laboratory and in-vitro research (R&D) use only. It is not a drug, food, supplement, or cosmetic, and is not intended for human or veterinary consumption, diagnostic, or therapeutic use. Not for use in humans or animals. Purchaser must be 18+ and confirms this material will be handled only by qualified researchers in a controlled laboratory setting, in accordance with UK law.